KRUSE BO (EVP, CFO, Secy & Treas.) sold 2.1% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $31.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/7/2022ACC: 0001104659-22-012870
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$31.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$7.97
Trade value
$31.88K
% of position
2.1%
2/4/2022
189.08K→185.08K
Total
Net shares
−4K
Net value
-$31.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2022 | S · Sale | −4K | $7.97 | $31.88K | 2.1% | 189.08K | 185.08K |
| Total | −4K | -$31.88K | ||||||
Derivative Transactions0
No derivative transactions reported